Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients

Steven E. Schumacher(Broad Institute), Rameen Beroukhim(Broad Institute), Franco Roviello(University of Siena), Gordon Saksena, Ramesh A. Shivdasani(Harvard University), Giovanni Corso(University of Siena), Adam J. Bass(Dana-Farber Cancer Institute), Min‐Hee Ryu(Ulsan College), Yoon‐Koo Kang(Ulsan College), Shouyong Peng(Dana-Farber Cancer Institute), Byoung Yong Shim(The Catholic University of Korea St. Vincent's Hospital)
PLoS ONE
April 20, 2017
10.1371/journal.pone.0176045
Cited by 61

Related Papers

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
|The Lancet|2010|7.3k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.6k
Comprehensive molecular profiling of lung adenocarcinoma
|Nature|2014|5.9k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k